Relationship between 6- and 9-month progression-free survival and overall survival in patients with metastatic urothelial cancer treated with first-line cisplatin-based chemotherapy

Galsky M.D.Krege S.CHIA-CHI LINHahn N.Ecke T.Moshier E.Sonpavde G.Godbold J.Oh W.K.Bamias A.2022-09-152022-09-1520130008-543Xhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84881478740&doi=10.1002%2fcncr.28145&partnerID=40&md5=3fe2b882337f9e6e6465a3c588921db6https://scholars.lib.ntu.edu.tw/handle/123456789/620318[SDGs]SDG3Relationship between 6- and 9-month progression-free survival and overall survival in patients with metastatic urothelial cancer treated with first-line cisplatin-based chemotherapyjournal article10.1002/cncr.28145237201972-s2.0-84881478740